JOHNSON & JOHNSON : Early, Deep, Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) Observed in Phase 1b/2 CARTITUDE-1 Study Show Potential of BCMA CAR-T in Treatment of Heavily Pretreated Patients with Multiple Myeloma

Press/Media

Period	7 Dec 2020

Media coverage

Title	JOHNSON & JOHNSON : Early, Deep, Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) Observed in Phase 1b/2 CARTITUDE-1 Study Show Potential of BCMA CAR-T in Treatment of Heavily Pretreated Patients with Multiple Myeloma
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	7/12/20
URL	https://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-Early-Deep-Durable-Responses-of-Ciltacabtagene-Autoleucel-cilta-cel-Observed-31955056/
Persons	Deepu Madduri